The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
11 reports and counting
Illumina raises $60B Public at $65B valuation
Illumina raises $60B in Public at $65B valuation. Biotechnology company...
Illumina raises $40B Public at $45B valuation
Illumina raises $40B in Public at $45B valuation. Gene sequencing company...
Illumina Raises $60B in Public
Illumina, a Biotech company based in 5200 Illumina Way, San Diego, CA 92122, has raised $60B in Public at a $65B valuation led by Public.
Where is Illumina's Headquarters? Main Office Location
Illumina's global headquarters is located at 5200 Illumina Way, San Diego, CA 92122. The office serves as the central hub for the company's Biotech operations.
Illumina transforms genomics industry with $100M IPO at $50B valuation
Illumina achieves $50B valuation through $100M IPO funding, establishing dominance in the genomics market with innovative dna sequencing and array-based technology platform.
Illumina Headquarters - Office Location & Address
Discover Illumina's headquarters at 5200 Illumina Way, San Diego, CA 92122. Biotechnology company. Learn about the office facilities and work environment.
Illumina Inc Headquarters - Office Location & Address
Discover Illumina Inc's headquarters at 5200 Illumina Way, San Diego, CA 92122. Genomics and DNA sequencing company enabling analysis of genetic variation and function. Market leader in next-generation sequencing technology powering breakthroughs in cancer, reproductive health, and genetic disease research.. Learn about the office facilities and work environment.
Truveta Raises $320M in Growth
Truveta, a HealthTech company based in Seattle, WA, has raised $320M in Growth at a $1B valuation led by Regeneron Pharmaceuticals, Illumina.
Truveta raises $320M Growth at $1B valuation
Truveta raises $320M in Growth at $1B valuation. Medical data research platform aggregating health system data for clinical insights...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.